🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Medpace Holdings, Inc.
Clinical Research-Based Drug and Medical Device Development Services
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services across North America, Europe, and Asia, supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.
About | About | About | About | About | Leadership | About | Locations | About | Contact | Contact | About | About | DEI | Benefits | About | About | Careers | Careers | Jobs | Locations | Careers | Careers | Careers | Careers | Jobs | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Site Map | About | About | About
Symbol: MEDP
Recent Price: $333.34
Industry: Medical - Diagnostics & Research
CEO: Dr. August James Troendle M.D.
Sector: Healthcare
Employees: 5900
Address: 5375 Medpace Way, Cincinnati, OH 45227
Phone: 513 579 9911
Leadership
- August Troendle, MD, Chief Executive Officer & Chairman of the Board of Directors
- Jesse Geiger, President
- Susan Burwig, MA, BSN, Executive Vice President, Operations
- Weimin Gai, MS, Senior Vice President,Biometrics
- Reinilde Heyrman, MD, Chief Medical Officer, Medical Department
- Gina Leisring, MPH, Senior Vice President, Clinical Monitoring
- Traci Turner, MD, Vice President, MRL Operations and MARC
- Brad Hansman, Vice President, Site Activation & Maintenance
- Kevin Brady, Chief Financial Officer
- Amy Gasser Callow, JD, Vice President, Human Resources and Assistant General Counsel
- Brandon Ebken, Chief Information Officer
- Stephen Ewald, JD, General Counsel, Chief Compliance Officer and Corporate Secretary
- Jennifer Ruth, Vice President, Quality Assurance and Process Improvement
- Todd Meyers, Vice President, Business Development and Marketing
- John T. Wynne, MBA, Senior Vice President, Commercial Operations and Phase I Unit
Last updated: 2024-12-31